Table 1 Clinicopathological features and ASAP1 in GC.

From: ASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer

Clinicopathological features

All patients (n = 547)

Low (n = 107, 19.0%)

High (n = 457, 81.0%)

P-value

Gender

   

0.141

   Male

410

274

136

 

   Female

137

99

38

 

Ageb

   

0.008a

   <60

178

134

44

 

   ≥60

369

239

130

 

Tumor sizeb

   

0.189

   <4 cm

340

237

103

 

   ≥4 cm

207

136

71

 

Invasion depth

   

0.021a

   T1 + T2

152

114

38

 

   T3 + T4

395

259

136

 

lymphatic metastasis

   

0.232

   N0 + N1

253

177

76

 

   N2 + N3

294

196

98

 

Distant metastases

   

0.292

   No

512

357

164

 

   Yes

26

16

10

 

TNM classification

   

0.037a

   I + II

181

133

48

 

   / III + IV

366

240

126

 

Differentiation

   

0.245a

   Moderat + Well

319

215

104

 

   Poor

198

140

58

 
  1. aStatistically significant (P < 0.05).